Real-time enrollment status for this non small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:09 PM UTC
| NCT Number | NCT05983432 |
| Recruiting Status | Recruiting |
| Condition | Non Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 540 participants |
| Active Locations | 22 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | September 21, 2026 (Sep 21, 2026) |
As of October 21, 2026: Clinical trial NCT05983432 is currently recruiting participants. This phase1 study for non small cell lung cancer is actively seeking new participants at 22 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05983432 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05983432 was last updated Sep 21, 2026 (September 21, 2026). HelloStudys verifies this status automatically.